115 related articles for article (PubMed ID: 7709160)
1. Detection of steroid receptors in breast cancer: relationship between EIA and IHC methods.
Lerma E; Esqué C; Peiró G; Mora J; Cerdá I; Prat J
Scand J Clin Lab Invest; 1994 Dec; 54(8):591-4. PubMed ID: 7709160
[TBL] [Abstract][Full Text] [Related]
2. High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases.
Zafrani B; Aubriot MH; Mouret E; De Crémoux P; De Rycke Y; Nicolas A; Boudou E; Vincent-Salomon A; Magdelénat H; Sastre-Garau X
Histopathology; 2000 Dec; 37(6):536-45. PubMed ID: 11122436
[TBL] [Abstract][Full Text] [Related]
3. [Human breast cancer embedded in paraffin, fixed in Bouin's fluid. Immunohistochemical analysis of estrogen and progesterone receptors].
Jacquemier J; Boudaoura T; Martin PM; Torrente M; Hassoun J
Ann Pathol; 1991; 11(4):224-30. PubMed ID: 1958256
[TBL] [Abstract][Full Text] [Related]
4. Steroid receptor measurement in breast cancers: comparison between ligand binding and enzyme-immunoassay in cytosolic and nuclear extracts.
Luqmani YA; Temmim L; Memon A; Ali MA; Parkar AH
Int J Cancer; 1997 May; 71(4):526-38. PubMed ID: 9178804
[TBL] [Abstract][Full Text] [Related]
5. Estrogen and progesterone receptors in breast cancer: comparison between enzyme immunoassay and computer-assisted image analysis of immunocytochemical assay.
Cavaliere A; Bucciarelli E; Sidoni A; Bianchi G; Pietropaoli N; Ludovini V; Vitali R
Cytometry; 1996 Sep; 26(3):204-8. PubMed ID: 8889392
[TBL] [Abstract][Full Text] [Related]
6. Comparison between single saturating dose ligand binding assay and enzyme immunoassay for low-salt extractable oestrogen and progesterone receptors in breast cancer: a multicentre study.
Gion M; Dittadi R; Leon AE; Bruscagnin G; Pelizzola D; Giovannini G; Giganti M; Messeri G; Quercioli M; Flamini E
Eur J Cancer; 1991; 27(8):996-1002. PubMed ID: 1832912
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of sex steroid receptors in breast cancer using routine paraffin sections: comparison with frozen sections and enzyme immunoassay.
Elias JM; Margiotta M; Sexton TR; Heimann A
J Cell Biochem Suppl; 1994; 19():126-33. PubMed ID: 7823584
[TBL] [Abstract][Full Text] [Related]
8. Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer.
Neven P; Van Calster B; Van den Bempt I; Van Huffel S; Van Belle V; Hendrickx W; Decock J; Wildiers H; Paridaens R; Amant F; Leunen K; Berteloot P; Timmerman D; Van Limbergen E; Weltens C; Van den Bogaert W; Smeets A; Vergote I; Christiaens MR; Drijkoningen M
Breast Cancer Res Treat; 2008 Jul; 110(1):153-9. PubMed ID: 17687649
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancer.
Kuenen-Boumeester V; Van der Kwast TH; van Putten WL; Claassen C; van Ooijen B; Henzen-Logmans SC
Int J Cancer; 1992 Oct; 52(4):581-4. PubMed ID: 1399140
[TBL] [Abstract][Full Text] [Related]
10. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.
Konecny G; Pauletti G; Pegram M; Untch M; Dandekar S; Aguilar Z; Wilson C; Rong HM; Bauerfeind I; Felber M; Wang HJ; Beryt M; Seshadri R; Hepp H; Slamon DJ
J Natl Cancer Inst; 2003 Jan; 95(2):142-53. PubMed ID: 12529347
[TBL] [Abstract][Full Text] [Related]
11. ER-negative /PR-positive breast carcinomas or technical artifacts in immunohistochemistry?
Maleki Z; Shariat S; Mokri M; Atri M
Arch Iran Med; 2012 Jun; 15(6):366-9. PubMed ID: 22642247
[TBL] [Abstract][Full Text] [Related]
12. [Hormone receptor determination in breast cancer using the dextran- coated charcoal method and monoclonal antibodies: correlation with cytomorphologic grading].
Schenck U; Jütting U; Eiermann W
Onkologie; 1988 Oct; 11(5):211-5. PubMed ID: 3059248
[TBL] [Abstract][Full Text] [Related]
13. Reverse transcription-polymerase chain reaction (RT-PCR) assays of estrogen and progesterone receptors in breast cancer.
Chevillard S; Müller A; Levalois C; Lainé-Bidron C; Vielh P; Magdelénat H
Breast Cancer Res Treat; 1996; 41(1):81-9. PubMed ID: 8932879
[TBL] [Abstract][Full Text] [Related]
14. Comparison of estrogen receptor, progesterone receptor and HER2 results in concurrent ipsilateral samples with invasive breast carcinoma: a retrospective study of 246 biopsies from 119 patients.
Singh K; Wang Y; Marketkar S; Kalife ET; Steinhoff MM
Hum Pathol; 2017 Jul; 65():123-132. PubMed ID: 28457730
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries.
Rhodes A; Jasani B; Balaton AJ; Miller KD
J Clin Pathol; 2000 Apr; 53(4):292-301. PubMed ID: 10823126
[TBL] [Abstract][Full Text] [Related]
16. Comparison of standardized immunohistochemical and biochemical assays for estrogen and progesterone receptors in breast carcinoma.
Golouh R; Vrhovec I; Bracko M; Frković-Grazio S
Pathol Res Pract; 1997; 193(8):543-9. PubMed ID: 9406247
[TBL] [Abstract][Full Text] [Related]
17. Cytologic diagnosis of estrogen and progesterone receptors in breast imprints.
Sasaki M; Morimoto K; Koh M; Wakasa K; Haba T; Kinoshita H
Acta Cytol; 2002; 46(6):1056-60. PubMed ID: 12462082
[TBL] [Abstract][Full Text] [Related]
18. [Inconsistency in quantitation of estrogen receptor and progesterone receptor with dextran charcoal method and enzyme immunoassay].
Morimoto K; Hasuma T; Koh M; Ohtani S; Kinoshita H
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1597-605. PubMed ID: 12355945
[TBL] [Abstract][Full Text] [Related]
19. [Expression of oestrogen receptor-beta in invasive breast tumours].
Péter I; Számel I; Péley G
Magy Onkol; 2004; 48(1):63-9. PubMed ID: 15105898
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A
Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
